Commentary: 'What's in a name? That which we call a rose by any other name would smell as sweet.' Shakespeare W. Romeo and Juliet, II, ii(47-48).

with and without other evidence of central nervous system pathology. Appl Neuropsychol 1999;6:3–11. 18 Kaplan RF, Meadows ME, Vincent LC, Logigian EL, Steere AC. Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and nonpsychotically depressed patients. Neurology 1992;42:1263–67. 19 Bujak DI, Weinstein A, Dornbush RL. Clinical and neurocognitive features of the post Lyme syndrome. J Rheumatol 1996;23:1392–97. 20 Tager FA, Fallon BA, Keilp J, Rissenberg M, Jones CR, Liebowitz MR. A controlled study of cognitive deficits in children with chronic Lyme disease. J Neuropsychiatry Clin Neurosci 2001;13:500–7. 21 Fallon BA, Keilp J, Prohovnik I, Heertum RV, Mann JJ. Regional blood flow and cognitive deficits in chronic Lyme disease. J Neuropsychiatry Clin Neurosci 2003;15:326–32. 22 Elkins LE, Pollina DA, Scheffer SR, Krupp LB. Psychological states and neuropsychological performances in chronic Lyme disease. Appl Neuropsychol 1999;6:19–26. 23 Weinstein A, Klempner MS. Treatment of patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001; 345:1424–25. 24 Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest 2004;113:1093–101. 25 Klempner MS, Linden TH, Evans J et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001;345:85–92. 26 Kaplan RF, Trevino RP, Johnson GM et al. Cognitive function in posttreatment Lyme disease. Do additional antibiotics help? Neurology 2003;60:1916–22. 27 Krupp LB, Hyman LG, Grimson R et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 2003;60:1923–30. 28 German National Reference Centre for Borreliosis. Lyme Borreliosis [in German]. Available at: http://pollux.mpk.med.uni-muenchen.de/ alpha1/nrz-borrelia/lb (Accessed November 25, 2004). 29 O’Connell S, Granstroem M, Gray JS, Stanek G. Epidemiology of European Lyme borreliosis. Zentr bl Bakteriol 1998;287:229–40. 30 Orloski KA, Hayes EB, Campbell GL, Dennis DT. Surveillance for Lyme disease—United States 1992–1998. Centers for Disease Control and Prevention Surveillance Summaries. MMWR Morb Mortal Wkly Rep 2000;49:1–11. 31 Centers for Disease Control and Prevention. Lyme disease— United States, 2001–2002. MMWR Morb Mortal Wkly Rep 2004; 53:365–69. 32 Meek JI, Roberts CL, Smith EV Jr, Cartter ML. Underreporting of Lyme disease by Connecticut physicians, 1992. J Public Health Manag Pract 1996;2:61–65. 33 Coyle BS, Strickland GT, Liang YY, Pena C, McCarter R, Israel E. Public impact of Lyme disease in Maryland. J Infect Dis 1996;173: 1260–62.